Biocryst Pharma Correlations

BCRX
 Stock
  

USD 12.36  0.34  2.68%   

The correlation of Biocryst Pharma is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biocryst Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biocryst Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Continue to Trending Equities.
  
The ability to find closely correlated positions to Biocryst Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biocryst Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biocryst Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biocryst Pharma to buy it.

Moving together with Biocryst Pharma

+0.74SGMLSigma Lithium CorpPairCorr

Moving against Biocryst Pharma

-0.55NVONovo Nordisk ASPairCorr
-0.54NONOFNOVO NORDISK ASPairCorr

Related Correlations

MURGY
ACGL
HIG
PGR
IFCZF
MET
ZURVY
MURGY
0.690.410.750.710.730.5
MURGY
ACGL
0.690.860.850.640.90.75
ACGL
HIG
0.410.860.650.450.820.77
HIG
PGR
0.750.850.650.80.840.57
PGR
IFCZF
0.710.640.450.80.730.6
IFCZF
MET
0.730.90.820.840.730.82
MET
ZURVY
0.50.750.770.570.60.82
ZURVY
MURGY
ACGL
HIG
PGR
IFCZF
MET
ZURVY
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

The Correlation Coefficient is a useful tool to identify correlated or non-correlated securities, which is essential in developing a diversified portfolio. It tells us the relationship between two positions you have in your portfolio or considering acquiring. Over a given time period, the two securities movetogether when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
METACGL
HIGACGL
PGRACGL
METPGR
METHIG
ZURVYMET
  

Biocryst Pharma Competition Risk-Adjusted Indicators

Nowadays, there is a big difference between Biocryst Stock performing well and Biocryst Pharma company doing well compared to the competition. There are way too many exceptions to the normal that investors can tell for sure what's good or bad unless they analyze Biocryst Pharma's multiple risk-adjusted performance indicators. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Biocryst Pharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Fundamentals Comparison Now

   

Fundamentals Comparison

Compare fundamentals across multiple equities to find investing opportunities
All  Next Launch Module

Biocryst Pharma Corporate Directors

Biocryst Pharma corporate directors refer to members of a Biocryst Pharma board of directors. The board of directors generally takes responsibility for the Biocryst Pharma's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Biocryst Pharma's board members must vote for the resolution. The Biocryst Pharma board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Fred Cohen - DirectorProfile
Stanley Erck - Independent DirectorProfile
Robert Ingram - DirectorProfile
Charles Sanders - Independent DirectorProfile

Invested in Biocryst Pharma?

The danger of trading Biocryst Pharma is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Biocryst Pharma is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Biocryst Pharma. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Biocryst Pharma is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Continue to Trending Equities. You can also try Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Complementary Tools for analysis

When running Biocryst Pharma price analysis, check to measure Biocryst Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biocryst Pharma is operating at the current time. Most of Biocryst Pharma's value examination focuses on studying past and present price action to predict the probability of Biocryst Pharma's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Biocryst Pharma's price. Additionally, you may evaluate how the addition of Biocryst Pharma to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Is Biocryst Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biocryst Pharma. If investors know Biocryst will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biocryst Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Biocryst Pharma is measured differently than its book value, which is the value of Biocryst that is recorded on the company's balance sheet. Investors also form their own opinion of Biocryst Pharma's value that differs from its market value or its book value, called intrinsic value, which is Biocryst Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biocryst Pharma's market value can be influenced by many factors that don't directly affect Biocryst Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biocryst Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine Biocryst Pharma value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biocryst Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.